Mostrar el registro sencillo del ítem

dc.contributor.authorGil-Prieto, Ruth
dc.contributor.authorPascual-Garcia, Raquel
dc.contributor.authorSan-Roman-Montero, Jesus
dc.contributor.authorMartínez-Martín, Pablo 
dc.contributor.authorCastrodeza-Sanz, Javier
dc.contributor.authorGil-de-Miguel, Ángel
dc.date.accessioned2022-05-25T10:02:33Z
dc.date.available2022-05-25T10:02:33Z
dc.date.issued2016-03-15
dc.identifier.citationPLoS One. 2016 Mar 15;11(3):e0151563.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14520
dc.description.abstractIntroduction: This epidemiological survey estimates the hospitalization burden related to Parkinson´s Disease in Spain. Methods: This observational retrospective survey was performed by reviewing data from the National Surveillance System for Hospital Data, which includes more than 98% of Spanish hospitals. All hospitalizations of patients with Parkinson´s disease that were reported from 1997-2012 were analyzed. Codes were selected using the 9th International Classification of Diseases: ICD-9-CM: 332.0. Results: A total of 438,513 hospital discharges of patients with Parkinson´s Disease were reported during the study period. The annual hospitalization rate was 64.2 cases per 100,000. The average length of hospital stay was 10 days. The trend for the annual hospitalization rate differed significantly depending on whether Parkinson´s disease was the main cause of hospitalization (n = 23,086, 1.14% annual increase) or was not the main cause of hospitalization (n = 415,427, 15.37% annual increase). The overall case-fatality rate among hospitalized patients was 10%. The case fatality rate among patient´s hospitalized with Parkinson´s disease as the main cause of hospitalization was 2.5%. The hospitalization rate and case-fatality rate significantly increased with age. The primary causes of hospitalization when Parkinson´s disease was not coded as the main cause of hospitalization were as follows: respiratory system diseases (24%), circulatory system diseases (19%), injuries and poisoning, including fractures (12%), diseases of the digestive system (10%) and neoplasms (5%). The annual average cost for National Health Care System was € 120 M, with a mean hospitalization cost of €4,378. Conclusions: Parkinson´s disease poses a significant health threat in Spain, particularly in the elderly. While hospitalizations due to Parkinson´s Disease are relatively stable over time, the number of patients presenting with Parkinson´s disease as an important comorbidity has increased dramatically. Medical staff must be specifically trained to treat the particular needs of hospitalized patients suffering from Parkinson´s disease as an important comorbidity.es_ES
dc.description.sponsorshipFunding sources for study: The cathedra “Evaluación de Resultados en Salud. Rey Juan Carlos University” is sponsored by Abbvie.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Science (PLOS) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAge Factors es_ES
dc.subject.meshAged es_ES
dc.subject.meshAged, 80 and over es_ES
dc.subject.meshCardiovascular Diseases es_ES
dc.subject.meshComorbidity es_ES
dc.subject.meshDiabetes Mellitus es_ES
dc.subject.meshDigestive System Diseases es_ES
dc.subject.meshEmergency Service, Hospitales_ES
dc.subject.meshFemale es_ES
dc.subject.meshHealth Care Surveys es_ES
dc.subject.meshHospital Mortality es_ES
dc.subject.meshHospitalization es_ES
dc.subject.meshHospitals, Public es_ES
dc.subject.meshHumans es_ES
dc.subject.meshHyperlipidemias es_ES
dc.subject.meshInternational Classification of Diseases es_ES
dc.subject.meshMale es_ES
dc.subject.meshMiddle Aged es_ES
dc.subject.meshNational Health Programs es_ES
dc.subject.meshNeoplasms es_ES
dc.subject.meshParkinson Disease es_ES
dc.subject.meshPatient Discharge es_ES
dc.subject.meshRespiration Disorders es_ES
dc.subject.meshRetrospective Studies es_ES
dc.subject.meshSpain es_ES
dc.subject.meshWounds and Injuries es_ES
dc.titleMeasuring the Burden of Hospitalization in Patients with Parkinson´s Disease in Spaines_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID26977930es_ES
dc.format.volume11es_ES
dc.format.number3es_ES
dc.format.pagee0151563es_ES
dc.identifier.doi10.1371/journal.pone.0151563es_ES
dc.contributor.funderAbbVie es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1932-6203es_ES
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0151563es_ES
dc.identifier.journalPloS Onees_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional